I-RECOVER Trademark

Trademark Overview


On Wednesday, February 9, 2022, a trademark application was filed for I-RECOVER with the United States Patent and Trademark Office. The USPTO has given the I-RECOVER trademark a serial number of 97260525. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 15, 2023. This trademark is owned by Front Line COVID-19 Critical Care Alliance Inc.. The I-RECOVER trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information in the nature of providing and preparing medical treatment protocols for individuals infected with COVID-19 and other infectious diseases; Providing a web site that gives medical information about the treatment of COVID-19 and other infectious diseases

Development of quality control standards for testing and medical treatment procedures for individuals infected with COVID-19 and other infectious diseases; Research and development of pharmaceuticals and medical procedures for the treatment of individuals infected with COVID-19 and other infectious diseases; Scientific study and research regarding effective treatment protocols for individuals infected with COVID-19 and other infectious diseases
i-recover

General Information


Serial Number97260525
Word MarkI-RECOVER
Filing DateWednesday, February 9, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding medical information in the nature of providing and preparing medical treatment protocols for individuals infected with COVID-19 and other infectious diseases; Providing a web site that gives medical information about the treatment of COVID-19 and other infectious diseases
Goods and ServicesDevelopment of quality control standards for testing and medical treatment procedures for individuals infected with COVID-19 and other infectious diseases; Research and development of pharmaceuticals and medical procedures for the treatment of individuals infected with COVID-19 and other infectious diseases; Scientific study and research regarding effective treatment protocols for individuals infected with COVID-19 and other infectious diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code042
First Use Anywhere DateWednesday, June 16, 2021
First Use In Commerce DateWednesday, June 16, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code044
First Use Anywhere DateWednesday, June 16, 2021
First Use In Commerce DateWednesday, June 16, 2021

Trademark Owner History


Party NameFront Line COVID-19 Critical Care Alliance Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWashington, DC 20036

Trademark Events


Event DateEvent Description
Monday, May 15, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, May 15, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, May 15, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION E-MAILED
Tuesday, October 4, 2022NON-FINAL ACTION WRITTEN
Thursday, September 29, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 12, 2022NEW APPLICATION ENTERED